摘要
目的研究肝动脉化疗栓塞(TACE)术联合放疗治疗原发性肝癌并发门静脉癌栓疗效及免疫指标影响。方法以射阳县人民医院2016年8月-2019年8月期间收治的原发性肝癌并发门静脉癌栓患者62例作为研究对象,按治疗方案不同分成两组,各31例,对照组给予TACE术治疗,研究组在此基础上联合放疗治疗。比较两组疗效。结果研究组患者的缓解率和稳定率显著高于对照组(P<0.05),研究组患者的肝功能和肝癌活性指标明显优于对照组(P<0.05)。结论肝动脉化疗栓塞(TACE)术联合放疗治疗原发性肝癌并发门静脉癌栓疗效与免疫指标更好。
Objective To study the effect and immune indexes of hepatic transcatheter arterial chemoembolization(TACE)combined with radiotherapy on primary hepatocellular carcinoma complicated with portal vein thrombus.Methods A total of 62 patients with primary hepatocellular carcinoma complicated with portal vein thrombus admitted to the people's hospital of shayang county from August 2016 to August 2019 were selected as the study subjects.They were divided into two groups with 31 cases each according to different treatment regimens.The control group was treated with TACE,and the research group was treated with TACE combined with radiotherapy.The efficacy of the two groups was compared.Results The remission rate and stabilization rate of patients in the study group were significantly higher than those in the control group(P<0.05),and the indexes of liver function and liver cancer activity in the study group were significantly better than those in the control group(P<0.05).Conclusion TACE combined with radiotherapy in the treatment of primary hepatocellular carcinoma complicated with portal vein thrombus has better efficacy and immune index.
作者
邓成清
时海峰
唐爱群
DENG Chengqing;SHI Haifeng;TANG Aiqun(Department of Intervention,Sheyang county people's hospital,Yancheng Jiangsu 224300,China;Department of oncology,Sheyang county people's hospital,Yancheng Jiangsu 224300,China;Department of Internal Medicine,Sheyang county people's hospital,Yancheng Jiangsu 224300,China)
出处
《临床研究》
2020年第4期7-9,共3页
Clinical Research
关键词
肝动脉化疗栓塞
放疗
原发性肝癌
门静脉癌栓
免疫指标
hepatic transcatheter arterial chemoembolization
radiotherapy
primary hepatocellular carcinoma
portal vein thrombus
immune indexes
